GELTEQ LIMITED ORDINARY SHARES
NASDAQ: GELS (Gelteq Limited)
最近更新时间: 9小时之前0.990
-0.54 (-35.29%)
| 前收盘价格 | 1.53 |
| 收盘价格 | 0.940 |
| 成交量 | 6,045,783 |
| 平均成交量 (3个月) | 2,608,023 |
| 市值 | 10,603,949 |
| 价格/销量 (P/S) | 80.03 |
| 股市价格/股市净资产 (P/B) | 0.970 |
| 52周波幅 |
| 营业利益率 (TTM) | -2,518.17% |
| 稀释每股收益 (EPS TTM) | -0.350 |
| 季度收入增长率 (YOY) | 56.80% |
| 总债务/股东权益 (D/E MRQ) | 25.43% |
| 流动比率 (MRQ) | 0.080 |
| 营业现金流 (OCF TTM) | -1.07 M |
| 资产报酬率 (ROA TTM) | -8.04% |
| 股东权益报酬率 (ROE TTM) | -21.00% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 混合的 | 看涨 |
| Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 看涨 | |
| 股票 | Gelteq Limited | - | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.63 |
|
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Growth |
| 内部持股比例 | 60.36% |
| 机构持股比例 | 1.11% |
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合